https://www.selleckchem.com/pr....oducts/cep-18770.htm
and DOTA-urantide were successfully radiolabelled with 111Indium, the first one functioning as a UT agonist and the second one as a UT-biased ligand/antagonist. To allow tumour-specific targeting and prolong body distribution in preclinical models bearing some solid tumours, these radiolabelled urotensinergic analogues should be optimized for being used as potential molecular tools for diagnosis imaging or even treatment tools.Non-small-cell lung cancer (NSCLC) is the most common lung cancer subtype and accounts for more than 80% of a
Like
Comment
Share
